Ultrasound imaging and contrast agents: A safe alternative to MRI?

Minimally Invasive Therapy and Allied Technologies

Volumn 15, Issue 2, 2006, Pages 93-100

  Wink, Margot H ^a   Wijkstra, Hessel ^a   De La Rosette, Jean J M C H ^a   Grimbergen, Cornelis A ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Contrast media; Microbubbles; Safety; Ultrasonography

Indexed keywords

ALBUNEX; CONTRAST MEDIUM; ECHOVIST; FS 069; IODINATED CONTRAST MEDIUM; PERFLEXANE; PERFLUTREN; SHU 508; SONOVUE;

ANGIOGENESIS; BLEEDING; BLOOD VESSEL PERMEABILITY; BONE MALFORMATION; BREAST TUMOR; CANCER LOCALIZATION; CANCER THERAPY; CARDIOVASCULAR DISEASE; CELL DAMAGE; CONTRAST ECHOCARDIOGRAPHY; CONTRAST ENHANCEMENT; DOPPLER FLOWMETRY; DRUG DELIVERY SYSTEM; DRUG HYPERSENSITIVITY; DRUG TARGETING; DRUG TOLERABILITY; ECHOGRAPHY; ENDOTHELIUM INJURY; FLUSHING; GENE TRANSFER; HEART DISEASE; HEART MUSCLE CELL; HEART MUSCLE PERFUSION; HEART VENTRICLE CONTRACTION; HEAT SENSITIVITY; HEMOLYSIS; HORMONAL THERAPY; HUMAN; INFLAMMATION; INJECTION SITE PAIN; KIDNEY CANCER; LEFT HANDEDNESS; LIVER CELL CARCINOMA; LIVER TUMOR; LUNG CAVITATION; MICROBUBBLE; NEPHROTOXICITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE BIOPSY; PROSTATE CANCER; RADIATION DOSE; RADIATION EXPOSURE; RADIATION FIELD; RADIATION INJURY; RADIATION RESPONSE; RADIATION SAFETY; RADIOFREQUENCY; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; SEX DIFFERENCE; SHEAR STRESS; SIDE EFFECT; SIGNAL DETECTION; TASTE DISORDER; THROMBUS;

CONTRAST MEDIA; HUMANS; MAGNETIC RESONANCE IMAGING; MICROBUBBLES; SAFETY; ULTRASONOGRAPHY;

EID: 33744728296     PISSN: 13645706     EISSN: 13652931     Source Type: Journal    
DOI: 10.1080/13645700600674252     Document Type: Review

References (81)

1. Gramiak, R. and Shah, P. M. (1968) Echocardiography of the aortic root. Invest Radiol, 3, pp. 356-66.
2. Barnett, S. B. and Rott, H. D. and ter Haar, G. R. and Ziskin, M. C. and et al. (1997) The sensitivity of biological tissue to ultrasound. Ultrasound Med Biol, 23, pp. 805-12.
3. Barnett, S. B. and ter Haar, G. R. and Ziskin, M. C. and Rott, H. D. and et al. (2000) International recommendations and guidelines for the safe use of diagnostic ultrasound in medicine. Ultrasound Med Biol, 26, pp. 355-66.
4. Salvesen, KE A. (2002) EFSUMB: Safety tutorial: epidemiology of diagnostic ultrasound exposure during pregnancy-European committee for medical ultrasound safety (ECMUS). Eur J Ultrasound, 15, pp. 165-71.
5. Church, C. C. (2002) Spontaneous homogeneous nucleation, inertial cavitation and the safety of diagnostic ultrasound. Ultrasound Med Biol, 28, pp. 1349-64.
6. Flynn, H. G. (1982) Generation of transient cavities in liquids by microsecond pulses of ultrasound. J Acoustic Soc Am, 72, pp. 1926-32.
7. Deng, C. X. and Xu, Q. and Apfel, R. E. and Holland, C. K. (1996) In vitro measurements of inertial cavitation thresholds in human blood. Ultrasound Med Biol, 22, pp. 939-48.
8. Carstensen, E. L. and Gracewski, S. and Dalecki, D. (2000) The search for cavitation in vivo. Ultrasound Med Biol, 26, pp. 1377-85.
9. Nyborg, W. L. (2001) Biological effects of ultrasound: Development of safety guidelines. Part II: General review. Ultrasound Med Biol, 27, pp. 301-33.
10. Abramowicz, J. S. and Kossoff, G. and Marsal, K. and Ter, H. G. (2003) Safety Statement, 2000 (reconfirmed 2003). International Society of Ultrasound in Obstetrics and Gynecology (ISUOG). Ultrasound Obstet Gynecol, 21, pp. 100.
11. Nyborg, W. L. (2002) Safety of medical diagnostic ultrasound. Semin Ultrasound CT MR, 23, pp. 377-86.
12. Abbott, J. G. (1999) Rationale and derivation of MI and TI-a review. Ultrasound Med Biol, 25, pp. 431-41.
13. Apfel, R. E. and Holland, C. K. (1991) Gauging the likelihood of cavitation from short-pulse, low-duty cycle diagnostic ultrasound. Ultrasound Med Biol, 17, pp. 179-85.
14. de Jong, N. (2002) Mechanical index. Eur J Echocardiogr, 3, pp. 73-4.
15. de Jong, N. and Bouakaz, A. and Frinking, P. (2002) Basic acoustic properties of microbubbles. Echocardiography, 19, pp. 229-40.
16. de Jong, N. and Cornet, R. and Lancee, C. T. (1994) Higher Harmonics of Vibrating Gas-Filled Microspheres. 1. Simulations. Ultrasonics, 32, pp. 447-53.
17. Frinking, P. J. A. and de Jong, N. and Cespedes, E. (1999) Scattering properties of encapsulated gas bubbles at high ultrasound pressures. Journal of the Acoustical Society of America, 105, pp. 1989-96.
18. Verbeek, X. A. A. M. and Willigers, J. M. and Brands, P. J. and Ledoux, L. A. F. and et al. (1999) Measurement of the contrast agent intrinsic and native harmonic response with single transducer pulse waved ultrasound systems. Annals of Biomedical Engineering, 27, pp. 670-81.
19. Burns, P. N. (1996) Harmonic imaging with ultrasound contrast agents. Clinical Radiology, 51, pp. 50-5.
20. Shi, W. T. and Forsberg, F. (2000) Ultrasonic characterization of the nonlinear properties of contrast microbubbles. Ultrasound Med Biol, 26, pp. 93-104.
21. Forsberg, F. and Liu, J. B. and Chiou, H. J. and Rawool, N. M. and et al. (2000) Comparison of fundamental and wideband harmonic contrast imaging of liver tumors. Ultrasonics, 38, pp. 110-3.
22. Tiemann, K. and Lohmeier, S. and Kuntz, S. and Koster, J. and et al. (1999) Real-time contrast echo assessment of myocardial perfusion at low emission power: First experimental and clinical results using power pulse inversion imaging. Echocardiography-A Journal of Cardiovascular Ultrasound and Allied Techniques, 16, pp. 799-809.
23. Albrecht, T. and Hoffmann, C. W. and Schmitz, S. A. and Schettler, S. and et al. (2001) Phase-inversion sonography during the liver-specific late phase of contrast enhancement: Improved detection of liver metastases. American Journal of Roentgenology, 176, pp. 1191-8.
24. Lencioni, R. and Cioni, D. and Bartolozzi, C. (2002) Tissue harmonic and contrast-specific imaging: Back to gray scale in ultrasound. Eur Radiol, 12, pp. 151-65.
25. Phillips, P. and Gardner, E. (2004) Contrast-agent detection and quantification. Eur Radiol, 14((Suppl 8)), pp. 4-10.
26. Bouakaz, A. and Krenning, B. J. and Vletter, W. B. and ten Cate, F. J. and et al. (2003) Contrast superharmonic imaging: A feasibility study. Ultrasound in Medicine and Biology, 29, pp. 547-53.
27. Jakobsen, J. A. and Oyen, R. and Thomsen, H. S. and Morcos, S. K. (2005) Safety of ultrasound contrast agents. Eur Radiol, 15, pp. 941-5.
28. Albrecht, T. and Blomley, M. and Bolondi, L. and Claudon, M. and et al. (2004) Guidelines for the use of contrast agents in ultrasound. January 2004. Ultraschall Med, 25, pp. 249-56.
29. Correas, J. M. and Bridal, L. and Lesavre, A. and Mejean, A. and et al. (2001) Ultrasound contrast agents: Properties, principles of action, tolerance, and artifacts. Eur Radiol, 11, pp. 1316-28.
30. Schlief, R. and Alhassan, A. and Wiggins, J. and Schumann, W. and et al. (2002) Safety of the galactose-based ultrasound contrast agent levovist Academic Radiology 9 S240-S242
31. Cohen, J. L. and Cheirif, J. and Segar, D. S. and Gillam, L. D. and et al. (1998) Improved left ventricular endocardial border delineation and opacification with OPTISON (FS069), a new echocardiographic contrast agent - Results of a phase III multicenter trial. Journal of the American College of Cardiology, 32, pp. 746-52.
32. Bokor, D. and Chambers, J. B. and Rees, P. J. and Mant, T. G. and et al. (2001) Clinical safety of SonoVue, a new contrast agent for ultrasound imaging, in healthy volunteers and in patients with chronic obstructive pulmonary disease. Invest Radiol, 36, pp. 104-9.
33. Miller, D. L. and Thomas, R. M. (1995) Ultrasound Contrast Agents Nucleate Inertial Cavitation In-Vitro. Ultrasound in Medicine and Biology, 21, pp. 1059-65.
34. Holland, C. K. and Apfel, R. E. (1990) Thresholds for Transient Cavitation Produced by Pulsed Ultrasound in A Controlled Nuclei Environment. Journal of the Acoustical Society of America, 88, pp. 2059-69.
35. Brayman, A. A. and Church, C. C. and Miller, M. W. (1996) Re-evaluation of the concept that high cell concentrations "protect" cells in vitro from ultrasonically induced lysis. Ultrasound in Medicine and Biology, 22, pp. 497-514.
36. Shi, W. T. and Forsberg, F. and Tornes, A. and Ostensen, J. and et al. (2000) Destruction of contrast microbubbles and the association with inertial cavitation. Ultrasound Med Biol, 26, pp. 1009-19.
37. Poliachik, S. L. and Chandler, W. L. and Mourad, P. D. and Bailey, M. R. and et al. (1999) Effect of high-intensity focused ultrasound on whole blood with and without microbubble contrast agent. Ultrasound in Medicine and Biology, 25, pp. 991-8.
38. Everbach, E. C. and Makin, I. R. S. and Francis, C. W. and Meltzer, R. S. (1998) Effect of acoustic cavitation on platelets in the presence of an echo-contrast agent. Ultrasound in Medicine and Biology, 24, pp. 129-36.
39. Miller, D. L. and Gies, R. A. (1998) Enhancement of ultrasonically-induced hemolysis by perfluorocarbon-based compared to air-based echo-contrast agents. Ultrasound in Medicine and Biology, 24, pp. 285-92.
40. Hwang, J. H. and Brayman, A. A. and Reidy, M. A. and Matula, T. J. and et al. (2005) Vascular effects induced by combined 1-MHz ultrasound and microbubble contrast agent treatments in vivo. Ultrasound Med Biol, 31, pp. 553 - 64.
41. Kobayashi, N. and Yasu, T. and Yamada, S. and Kudo, N. and et al. (2003) Influence of contrast ultrasonography with perflutren lipid microspheres on microvessel injury. Circ J, 67, pp. 630-6.
42. Kobayashi, N. and Yasu, T. and Yamada, S. and Kudo, N. and et al. (2002) Endothelial cell injury in venule and capillary induced by contrast ultrasonography. Ultrasound Med Biol, 28, pp. 949-56.
43. Skyba, D. M. and Price, R. J. and Linka, A. Z. and Skalak, T. C. and et al. (1998) Direct in vivo visualization of intravascular destruction of microbubbles by ultrasound and its local effects on tissue. Circulation, 98, pp. 290-3.
44. Miller, D. L. and Li, P. and Dou, C. and Gordon, D. and et al. (2005) Influence of contrast agent dose and ultrasound exposure on cardiomyocyte injury induced by myocardial contrast echocardiography in rats. Radiology, 237, pp. 137-43.
45. Ay, T. and Havaux, X. and Van Camp, G. and Campanelli, B. and et al. (2001) Destruction of contrast microbubbles by ultrasound - Effects on myocardial function, coronary perfusion pressure, and microvascular integrity. Circulation, 104, pp. 461-6.
46. Li, P. and Cao, L. Q. and Dou, C. Y. and Armstrong, W. F. and et al. (2003) Impact of myocardial contrast echocardiography on vascular permeability: An in vivo dose response study of delivery mode, pressure amplitude and contrast dose. Ultrasound in Medicine and Biology, 29, pp. 1341-9.
47. Li, P. and Armstrong, W. F. and Miller, D. L. (2004) Impact of myocardial contrast echocardiography on vascular permeability: Comparison of three different contrast agents. Journal of the American College of Cardiology, 43, pp. 316A.
48. van der Wouw, P. A. and Brauns, A. C. and Bailey, S. E. and Powers, J. E. and et al. (2000) Premature ventricular contractions during triggered imaging with ultrasound contrast. Journal of the American Society of Echocardiography, 13, pp. 288-94.
49. Dijkmans, P. A. and Juffermans, L. J. and Musters, R. J. and van Wamel, A. and et al. Microbubbles and ultrasound: From diagnosis to therapy. Eur J Echocardiogr, 5, pp. 245-56.
50. Bekeredjian, R. and Grayburn, P. A. and Shohet, R. V. (2005) Use of ultrasound contrast agents for gene or drug delivery in cardiovascular medicine. Journal of the American College of Cardiology, 45, pp. 329-35.
51. Unger, E. C. and Hersh, E. and Vannan, M. and Matsunaga, T. O. and et al. (2001) Local drug and gene delivery through microbubbles. Progress in Cardiovascular Diseases, 44, pp. 45-54.
52. Feril, L. B. and Kondo, T. and Zhao, Q. L. and Ogawa, R. and Tachibana, K. and et al. (2003) Enhancement of ultrasound-induced apoptosis and cell lysis by echo-contrast agents. Ultrasound in Medicine and Biology, 29, pp. 331-7.
53. Chavrier, F. and Chapelon, J. Y. and Gelet, A. and Cathignol, D. (2000) Modeling of high-intensity focused ultrasound-induced lesions in the presence of cavitation bubbles. Journal of the Acoustical Society of America, 108, pp. 432-40.
54. Lindner, J. R. (2004) Molecular imaging with contrast ultrasound and targeted microbubbles. J Nucl Cardiol, 11, pp. 215-21.
55. Ellegala, D. B. and Leong-Poi, H. and Carpenter, J. E. and Klibanov, A. L. and et al. (2003) Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to alpha(v)beta3 Circulation 108 336-341
56. Lindner, J. R. (2002) Detection of inflamed plaques with contrast ultrasound. Am J Cardiol, 90, pp. 32L-35L.
57. Schumann, P. A. and Christiansen, J. P. and Quigley, R. M. and McCreery, T. P. and et al. (2002) Targeted-microbubble binding selectively to GPIIb IIIa receptors of platelet thrombi. Investigative Radiology, 37, pp. 587-93.
58. Leen, E. and Moug, S. J. and Horgan, P. (2004) Potential impact and utilization of ultrasound contrast media. Eur Radiol, 14((Suppl 8)), pp. 16-24.
59. Feinstein, S. B. (2004) The powerful microbubble: From bench to bedside, from intravascular indicator to therapeutic delivery system, and beyond. Am J Physiol Heart Circ Physiol, 287, pp. H450-7.
60. Elhendy, A. and Porter, T. R. (2005) Assessment of myocardial perfusion with real-time myocardial contrast echocardiography: Methodology and clinical applications. Journal of Nuclear Cardiology, 12, pp. 582-90.
61. Quaia, E. and Calliada, F. and Bertolotto, M. and Rossi, S. and et al. (2004) Characterization of focal liver lesions with contrast specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: Diagnostic performance and confidence. Radiology, 232, pp. 420-30.
62. Solbiati, L. and Tonolini, M. and Cova, L. and Goldberg, S. N. (2001) The role of contrast-enhanced ultrasound in the detection of focal liver leasions. Eur Radiol, 11((Suppl 3)), pp. E15-E26.
63. Solbiati, L. and Tonolini, M. and Cova, L. (2004) Monitoring RF ablation. Eur Radiol, 14((Suppl 8)), pp. 34-42.
64. Solbiati, L. and Ierace, T. and Tonolini, M. and Cova, L. (2004) Guidance and monitoring of radiofrequency liver tumor ablation with contrast-enhanced ultrasound. Eur J Radiol, 51((Suppl)), pp. S19-S23.
65. Coakley, F. V. and Qayyum, A. and Kurhanewicz, J. (2003) Magnetic resonance imaging and spectroscopic imaging of prostate cancer. Journal of Urology, 170, pp. S69-S75.
66. Jemal, A. and Murray, T. and Ward, E. and Samuels, A. and et al. (2005) Cancer statistics, 2005. CA Cancer J Clin, 55, pp. 10-30.
67. Bogers, H. A. and Sedelaar, J. P. and Beerlage, H. P. and de la Rosette, J. J. and et al. (1999) Contrast-enhanced three-dimensional power Doppler angiography of the human prostate: Correlation with biopsy outcome. Urology, 54, pp. 97-104.
68. Sedelaar, J. P. and van Leenders, G. J. and Goossen, T. E. and Hulsbergen-van der Kaa, C. A. and et al. (2002) Value of contrast ultrasonography in the detection of significant prostate cancer: correlation with radical prostatectomy specimens. Prostate, 53, pp. 246-53.
69. Sedelaar, J. P. and van Leenders, G. J. and Hulsbergen-van de Kaa, C. A. and van der Poel, H. G. and et al. (2001) Microvessel density: correlation between contrast ultrasonography and histology of prostate cancer. Eur Urol, 40, pp. 285-93.
70. Halpern, E. J. and Ramey, J. R. and Strup, S. E. and Frauscher, F. and et al. Detection of prostate carcinoma with contrast-enhanced sonography using intermittent harmonic imaging. Cancer, in press: Published online October, 20, pp. 2005.
71. Frauscher, F. and Klauser, A. and Volgger, H. and Halpern, E. J. and Pallwein, L. and et al. (2002) Comparison of contrast enhanced color Doppler targeted biopsy with conventional systematic biopsy: Impact on prostate cancer detection. J Urol, 167, pp. 1648-52.
72. Halpern, E. J. and Frauscher, F. and Rosenberg, M. and Gomella, L. G. (2002) Directed biopsy during contrast-enhanced sonography of the prostate. AJR Am J Roentgenol, 178, pp. 915-9.
73. Halpern, E. J. and McCue, P. A. and Aksnes, A. K. and Hagen, E. K. and et al. (2002) Contrast-enhanced US of the prostate with Sonazoid: comparison with whole-mount prostatectomy specimens in 12 patients Radiology 222 361-366
74. Goossen, T. E. and de la Rosette, J. J. and Hulsbergen-van de Kaa, C. A. and van Leenders, G. J. and et al. (2003) The value of dynamic contrast enhanced power Doppler ultrasound imaging in the localization of prostate cancer. Eur Urol, 43, pp. 124-31.
75. Eckersley, R. J. and Sedelaar, J. P. and Blomley, M. J. and Wijkstra, H. and et al. (2002) Quantitative microbubble enhanced transrectal ultrasound as a tool for monitoring hormonal treatment of prostate carcinoma. Prostate, 51, pp. 256-67.
76. Sedelaar, J. P. and Aarnink, R. G. and van Leenders, G. J. and Beerlage, H. P. and et al. (2000) The application of three-dimensional contrast-enhanced ultrasound to measure volume of affected tissue after HIFU treatment for localized prostate cancer. Eur Urol, 37, pp. 559-68.
77. Strohmeyer, D. and Frauscher, F. and Klauser, A. and Recheis, W. and et al. (2001) Contrast-enhanced transrectal color doppler ultrasonography (TRCDUS) for assessment of angiogenesis in prostate cancer. Anticancer Res, 21, pp. 2907-13.
78. Nilsson, A. (2004) Contrast-enhanced ultrasound of the kidneys. Eur Radiol, 14((Suppl 8)), pp. 104-9.
79. Zhu, Q. and Shimizu, T. and Endo, H. and Kodama, Y. and et al. (2005) Assessment of renal cell carcinoma after cryoablation using contrast-enhanced gray-scale ultrasound: A case series. Clin Imaging, 29, pp. 102-8.
80. Kettenbach, J. and Helbich, T. H. and Huber, A. and Zuna and et al. (2005) Computer-assisted quantitative assessment of power Doppler US: effects of microbubble contrast agent in the differentiation of breast tumors. European Journal of Radiology, 53, pp. 238-44.
81. Yang, W. T. and Metreweli, C. and Lam, P. K. W. and Chang, J. (2001) Benign and malignant breast masses and axillary nodes: Evaluation with echo-enhanced color power Doppler US. Radiology, 220, pp. 795-802.